-transparent.png){kind=logo}
Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. 1995
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
DuPont Merck Research Laboratories, DuPont Experimental Station, Wilmington, Delaware 19880-0353, USA.
Acyl-CoA:cholesterol acyltransferase (ACAT) is the primary enzyme involved in intracellular cholesterol esterification. Arterial wall infiltration by macrophages and subsequent uncontrolled esterification of cholesterol leading to foam cell formation is believed to be an important process which leads to the development of fatty streaks. Inhibitors of the ACAT enzyme may retard this atherogenic process. We have recently discovered a series of imidazoles which are potent in vitro ACAT inhibitors in the J774 macrophage cell culture assay. This paper will describe the design, synthesis, and structure--activity relationship for this very potent series of compounds.
Related Publications
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
March 2004,
Bioorganic & medicinal chemistry letters,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
April 1993,
Biochimica et biophysica acta,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
February 1998,
Bioorganic & medicinal chemistry letters,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
October 1993,
Journal of medicinal chemistry,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
July 1997,
Bioorganic & medicinal chemistry,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
May 2010,
Bioorganic & medicinal chemistry letters,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
April 1996,
Journal of medicinal chemistry,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
January 2008,
Arzneimittel-Forschung,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
January 1998,
Bioorganic & medicinal chemistry,
T P Maduskuie, and
R G Wilde, and
J T Billheimer, and
D A Cromley, and
S Germain, and
P J Gillies, and
C A Higley, and
A L Johnson, and
P Pennev, and
E J Shimshick
December 2022,
Journal of medicinal chemistry,
